A 4-year-old boy presents with vomiting and one day of lethargy after a one week history of flu-like symptoms and low-grade fevers. The vomiting is nonbilious and nonbloody. The patient has had no other symptoms aside from mild rhinorrhea and cough. He has no past medical history, and is on no medications except for over-the-counter medications for his fever. His temperature is 98.5°F (36.9°C), pulse is 96/min, respirations are 14/min, and blood pressure is 108/80 mmHg. The patient appears lethargic and is oriented only to person. Otherwise, the physical exam is benign and the patient has no other neurologic symptoms. What is the mechanism of the most likely cause of this patient’s presentation?
Q2
A 3-year-old boy is seen in clinic. He was born at home without perinatal care. He was apparently normal at birth, but later developed failure to thrive and developmental delay. He also has a history of cataracts. His older brother had a myocardial infarction at the age of 18 and is rather lanky and tall in appearance. Laboratory testing of his urine showed an increase in the level of an amino acid. What is the most likely mechanism responsible for this boy's pathology?
Q3
A newborn boy develops projectile vomiting 48 hours after delivery. He is found to be lethargic, with poor muscle tone, and is hyperventilating. Within hours, he suffers important neurological deterioration, leading to seizures, coma, and, ultimately, death. An autopsy is performed and the pathology team makes a diagnosis of a rare genetic disorder that leads to low levels of N-acetylglutamate. Which of the following enzymes would be secondarily affected by this process?
Q4
A 3-week old boy is brought to the physician for the evaluation of lethargy, recurrent vomiting, and poor weight gain since birth. Physical examination shows decreased skin turgor and a bulging frontal fontanelle. Serum studies show an ammonia concentration of 170 μmol/L (N < 30) and low serum citrulline levels. The oral intake of which of the following nutrients should be restricted in this patient?
Q5
A 16-year-old boy presents with acute left-sided weakness. The patient is obtunded and can not provide any history other than his stomach hurts. The patient’s friend states that the patient has had episodes like this in the past and that “he has the same weird disease as his mom”. On physical examination, strength is 1 out of 5 in the left upper and lower extremities. A noncontrast CT scan of the head is normal. Laboratory tests reveal an anion gap metabolic acidosis. Which of the following is a normal function of the structure causing this patient’s condition?
Urea cycle US Medical PG Practice Questions and MCQs
Question 1: A 4-year-old boy presents with vomiting and one day of lethargy after a one week history of flu-like symptoms and low-grade fevers. The vomiting is nonbilious and nonbloody. The patient has had no other symptoms aside from mild rhinorrhea and cough. He has no past medical history, and is on no medications except for over-the-counter medications for his fever. His temperature is 98.5°F (36.9°C), pulse is 96/min, respirations are 14/min, and blood pressure is 108/80 mmHg. The patient appears lethargic and is oriented only to person. Otherwise, the physical exam is benign and the patient has no other neurologic symptoms. What is the mechanism of the most likely cause of this patient’s presentation?
A. Deficient erythrocyte enzyme
B. Chemical ingestion
C. Bacterial infection
D. Irreversible enzyme inhibition (Correct Answer)
E. Reversible enzyme inhibition
Explanation: ***Irreversible enzyme inhibition***
- This presentation is highly suggestive of **Reye syndrome**, which is associated with **aspirin use** in children with viral illnesses. Aspirin (acetylsalicylic acid) **irreversibly inhibits cyclooxygenase (COX) enzymes** by acetylating a serine residue at the active site.
- While aspirin's primary mechanism is COX inhibition, **Reye syndrome** involves **mitochondrial dysfunction** in hepatocytes, leading to impaired fatty acid beta-oxidation, hyperammonemia, hepatic steatosis, and **encephalopathy**. This explains the vomiting, lethargy, and altered mental status after flu-like symptoms.
- The key connection is that aspirin acts through **irreversible enzyme inhibition**, making this the correct mechanistic classification for the causative agent.
*Reversible enzyme inhibition*
- While some aspects of Reye syndrome involve mitochondrial enzyme dysfunction, aspirin itself does **not** act through reversible competitive inhibition—it **irreversibly acetylates** COX enzymes.
- Reversible inhibition would imply the drug effect could be easily overcome by increasing substrate concentration, which is not the case with aspirin's mechanism.
*Deficient erythrocyte enzyme*
- This mechanism is associated with conditions like **glucose-6-phosphate dehydrogenase (G6PD) deficiency**, which primarily causes **hemolytic anemia** with jaundice and pallor.
- While G6PD deficiency can be triggered by certain medications, it does not typically present with the **encephalopathy** and liver dysfunction seen in this patient.
*Chemical ingestion*
- While aspirin is technically a chemical, the question asks about the **mechanism** rather than the route of exposure. The specific mechanism is irreversible enzyme inhibition.
- The history of **flu-like symptoms** and use of over-the-counter fever medications strongly suggests aspirin-associated Reye syndrome rather than accidental toxic ingestion.
*Bacterial infection*
- A severe bacterial infection (e.g., **bacterial meningitis** or **sepsis**) could cause lethargy and vomiting, but the clinical picture (normal vital signs, benign physical exam, no fever) is not typical for acute bacterial infection.
- The association with a recent **viral illness** and potential over-the-counter medication use strongly favors Reye syndrome, a non-infectious etiology.
Question 2: A 3-year-old boy is seen in clinic. He was born at home without perinatal care. He was apparently normal at birth, but later developed failure to thrive and developmental delay. He also has a history of cataracts. His older brother had a myocardial infarction at the age of 18 and is rather lanky and tall in appearance. Laboratory testing of his urine showed an increase in the level of an amino acid. What is the most likely mechanism responsible for this boy's pathology?
A. Hereditary defect of renal amino acid transporter
B. Inability to degrade branched chain amino acids
C. Cystathionine synthase deficiency (Correct Answer)
D. Deficiency of homogentisic acid oxidase
E. Deficiency of phenylalanine hydroxylase
Explanation: ***Cystathionine synthase deficiency***
- The constellation of **developmental delay, failure to thrive, cataracts**, and a history of **myocardial infarction** in an older sibling with a **marfanoid habitus** points to **homocystinuria**.
- **Cystathionine synthase deficiency** is the most common cause of homocystinuria, leading to an **accumulation of homocysteine** and methionine, which can be detected in urine.
*Hereditary defect of renal amino acid transporter*
- Conditions like **cystinuria** involve defective renal transport of specific amino acids (cystine, ornithine, lysine, arginine) but typically present with **kidney stones**, not cataracts or thrombotic events.
- This defect would lead to elevated levels of the affected amino acids in the urine but does not explain the systemic features observed.
*Inability to degrade branched chain amino acids*
- This describes **Maple Syrup Urine Disease**, characterized by the inability to metabolize **leucine, isoleucine, and valine**.
- It presents with symptoms like **poor feeding, lethargy, seizures, and a distinctive sweet odor** in urine, which are not detailed here, and generally has a more acute and severe neonatal presentation without a typical marfanoid habitus or thrombotic events.
*Deficiency of homogentisic acid oxidase*
- This deficiency causes **alkaptonuria**, an inborn error of tyrosine metabolism.
- It is characterized by **dark urine** upon standing, **ochronosis** (darkening of connective tissues), and **arthropathy**, none of which are consistent with the patient's symptoms.
*Decreased in phenylalanine hydroxylase*
- This is the enzyme deficient in **phenylketonuria (PKU)**, which leads to the accumulation of **phenylalanine**.
- PKU typically presents with **intellectual disability, seizures, fair skin, and a musty odor** if untreated, but generally does not involve cataracts or thrombotic events.
Question 3: A newborn boy develops projectile vomiting 48 hours after delivery. He is found to be lethargic, with poor muscle tone, and is hyperventilating. Within hours, he suffers important neurological deterioration, leading to seizures, coma, and, ultimately, death. An autopsy is performed and the pathology team makes a diagnosis of a rare genetic disorder that leads to low levels of N-acetylglutamate. Which of the following enzymes would be secondarily affected by this process?
A. Argininosuccinate lyase
B. Carbamoyl phosphate synthetase I (Correct Answer)
C. Argininosuccinate synthetase
D. Ornithine transcarbamylase
E. Arginase
Explanation: ***Carbamoyl phosphate synthetase I***
- **N-acetylglutamate** is an **obligate activator** for **Carbamoyl phosphate synthetase I (CPS I)**, the rate-limiting enzyme of the **urea cycle**. Low levels of N-acetylglutamate directly impair CPS I activity.
- Reduced CPS I activity leads to a severe **urea cycle disorder**, causing **hyperammonemia**, which manifests with lethargy, poor muscle tone, hyperventilation, neurological deterioration, seizures, coma, and death in newborns.
*Argininosuccinate lyase*
- This enzyme is involved downstream in the **urea cycle**, catalyzing the cleavage of **argininosuccinate** into **arginine** and **fumarate**.
- Its activity is not directly regulated by **N-acetylglutamate**, so it would not be secondarily affected in the same manner as CPS I.
*Argininosuccinate synthetase*
- This enzyme acts after CPS I and ornithine transcarbamylase in the **urea cycle**, synthesizing **argininosuccinate** from **citrulline** and **aspartate**.
- Its function is independent of **N-acetylglutamate** levels, making it unlikely to be secondarily affected.
*Ornithine transcarbamylase*
- This enzyme catalyzes the second step of the **urea cycle**, forming **citrulline** from **ornithine** and **carbamoyl phosphate**.
- While essential for the urea cycle, its activity is not directly modulated by **N-acetylglutamate**; rather, it depends on the availability of carbamoyl phosphate produced by CPS I.
*Arginase*
- This is the final enzyme in the **urea cycle**, converting **arginine** to **ornithine** and **urea**.
- Its activity is not directly or indirectly regulated by **N-acetylglutamate**, nor is it the enzyme primarily affected in this presentation.
Question 4: A 3-week old boy is brought to the physician for the evaluation of lethargy, recurrent vomiting, and poor weight gain since birth. Physical examination shows decreased skin turgor and a bulging frontal fontanelle. Serum studies show an ammonia concentration of 170 μmol/L (N < 30) and low serum citrulline levels. The oral intake of which of the following nutrients should be restricted in this patient?
A. Gluten
B. Lactose
C. Fructose
D. Protein (Correct Answer)
E. Vitamin A
Explanation: ***Protein***
- Elevated **ammonia** and low **citrulline** levels indicate a **urea cycle disorder**, which impairs the body's ability to excrete nitrogenous waste from protein metabolism.
- Restricting **protein intake** limits the production of ammonia, thereby reducing the toxic burden on the system and preventing further neurological damage.
*Gluten*
- **Gluten restriction** is primarily indicated for **celiac disease**, which presents with gastrointestinal symptoms like diarrhea, malabsorption, and poor weight gain, but not directly with hyperammonemia or urea cycle dysfunction.
- While malabsorption can cause poor weight gain, the specific metabolic derangements here point away from celiac disease.
*Lactose*
- **Lactose intolerance** or **galactosemia** would necessitate **lactose restriction**. Symptoms usually include vomiting, diarrhea, and failure to thrive, but they do not typically present with the extreme hyperammonemia seen here.
- Galactosemia specifically would show elevated galactose and galactose-1-phosphate, not ammonia.
*Fructose*
- **Hereditary fructose intolerance** requires **fructose restriction**. It generally presents with vomiting, hypoglycemia, and liver dysfunction (jaundice, hepatomegaly) upon exposure to fructose, not primarily with hyperammonemia.
- The metabolic pathway for fructose metabolism does not directly generate ammonia in the quantities seen with urea cycle disorders.
*Vitamin A*
- **Vitamin A restriction** is not a primary treatment for any known inborn error of metabolism or hyperammonemia.
- While deficiencies or toxicities of vitamins can occur, they do not present with the specific metabolic profile described (high ammonia, low citrulline).
Question 5: A 16-year-old boy presents with acute left-sided weakness. The patient is obtunded and can not provide any history other than his stomach hurts. The patient’s friend states that the patient has had episodes like this in the past and that “he has the same weird disease as his mom”. On physical examination, strength is 1 out of 5 in the left upper and lower extremities. A noncontrast CT scan of the head is normal. Laboratory tests reveal an anion gap metabolic acidosis. Which of the following is a normal function of the structure causing this patient’s condition?
A. Regulation of blood glucose
B. Synthesis of fatty acids
C. Production of bile acids
D. Metabolism of purines
E. Conversion of ammonia to urea (Correct Answer)
Explanation: ***Conversion of ammonia to urea***
- The patient's presentation with **acute neurological deficits**, **abdominal pain**, and **anion gap metabolic acidosis** with a normal head CT, along with family history, is highly suggestive of a **urea cycle disorder (UCD)**.
- The **urea cycle** primarily functions in the **liver** to convert **toxic ammonia** into less toxic urea for excretion.
*Regulation of blood glucose*
- While regulation of blood glucose is a vital **liver function**, it does not directly relate to the primary metabolic derangement (ammonia accumulation) seen in UCDs.
- **Hypoglycemia** can occur in some UCDs, but it's not the defining feature of the neurological crisis.
*Synthesis of fatty acids*
- **Fatty acid synthesis** primarily occurs in the liver and adipose tissue, but its dysfunction is not the direct cause of the patient's acute symptoms.
- While liver dysfunction can impact lipid metabolism, it is not the central pathological process in UCDs.
*Production of bile acids*
- **Bile acid production** is a critical function of the liver for fat digestion and absorption, but it is not directly impaired in urea cycle disorders.
- Bile acid synthesis disorders would present with different clinical features, such as **cholestasis** and fat malabsorption.
*Metabolism of purines*
- **Purine metabolism** occurs in various tissues, and its dysfunction can lead to conditions like **gout** or **Lesch-Nyhan syndrome**, which differ from the presented symptoms.
- Abnormalities in purine metabolism are not the core defect in urea cycle disorders.
